Form 4: ALHC CEO Sells Shares for Tax Obligations

Alignment Healthcare CEO John E. Kao sold over 600,000 shares of common stock to cover tax withholding obligations related to performance share unit vesting.

Summary

• John E. Kao, CEO and Director of Alignment Healthcare, Inc. (ALHC), sold a total of 605,648 shares of common stock.
• The sales were non-discretionary, executed solely to cover tax withholding obligations arising from the vesting of performance share units.
• 572,437 shares were sold on December 29, 2025, at a weighted-average price of $18.7056, with individual transaction prices ranging from $18.23 to $19.225.
• An additional 33,211 shares were sold on December 29, 2025, at a weighted-average price of $19.3818, with individual transaction prices ranging from $19.23 to $19.51.
• Following these transactions, Mr. Kao directly owns 2,234,294 shares and indirectly owns 2,346,726 shares through the JEK Trust, of which he is the trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a large number of shares were sold by the CEO, the explicit reason for the sale (tax withholding on vested performance units) indicates a non-discretionary event, which is generally not viewed as a negative signal about the company's future. The vesting itself implies performance targets were met.

Positives

• The transaction indicates the vesting of performance share units, suggesting that performance targets were met, which is generally a positive sign for the company.
• The sale was explicitly stated as non-discretionary and solely for tax purposes, not an indication of a lack of confidence in the company by the CEO.

Negatives

• A significant number of shares (605,648) were sold by a key executive, which could be perceived negatively by some investors, despite the stated reason.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it pertains solely to an insider transaction.

Management Comments

• The reported sales represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person.

Industry Context

This insider transaction filing is specific to Alignment Healthcare, Inc. and its CEO. While executive compensation structures involving performance share units and subsequent tax-related share sales are common across industries, this filing does not provide broader industry-specific trends or competitive analysis.

Comparison to Industry Standards

• The sale of shares by an executive to cover tax withholding obligations upon the vesting of equity awards is a standard and routine practice for executives across publicly traded companies. This mechanism is commonly used to manage the tax liability associated with non-cash compensation.
• The disclosure of weighted-average prices and price ranges for multiple transactions is standard practice for Form 4 filings when sales occur over a range of prices, ensuring transparency in executive compensation-related transactions.

Related Party Transactions

• John E. Kao indirectly holds 2,346,726 shares through the JEK Trust, dated February 8, 2021, of which he is the trustee. This represents a related party arrangement for beneficial ownership.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO, even for tax purposes, could lead to a minor, temporary negative sentiment due to the volume, but the non-discretionary nature mitigates this. The vesting of performance units could be seen as a positive indicator of company performance.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is mentioned or implied by this insider transaction filing.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each price within the stated ranges upon request to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission.

Key Dates

Recommendation

This Form 4 filing details a non-discretionary sale of shares by the CEO to cover tax obligations related to the vesting of performance share units. Such transactions are routine and do not typically signal a change in the executive's confidence in the company's prospects. Therefore, it provides no new fundamental information to warrant a change in investment recommendation. Investors should hold their position and look for more substantive financial or operational updates.

Keywords

Alignment Healthcare, ALHC, John E. Kao, CEO, Insider Trading, Form 4, Share Sale, Tax Withholding, Performance Share Units, Executive Compensation